BL Pharmtech Corp. (KOSDAQ:065170)
2,220.00
+95.00 (4.47%)
At close: Oct 2, 2026
BL Pharmtech Revenue
BL Pharmtech had revenue of 713.41M KRW in the quarter ending June 30, 2026, a decrease of -60.42%. This brings the company's revenue in the last twelve months to 3.09B, down -64.20% year-over-year. In the year 2025, BL Pharmtech had annual revenue of 6.51B, down -26.12%.
Revenue (ttm)
3.09B
Revenue Growth
-64.20%
P/S Ratio
20.05
Revenue / Employee
257.50M
Employees
12
Market Cap
61.96B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.51B | -2.30B | -26.12% |
| Dec 31, 2024 | 8.81B | -15.72B | -64.10% |
| Dec 31, 2023 | 24.53B | 2.00B | 8.89% |
| Dec 31, 2022 | 22.52B | -61.92B | -73.33% |
| Dec 31, 2021 | 84.44B | 18.75B | 28.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Daehan Nupharm | 211.48B |
| RP Bio | 141.42B |
| Jin Yang Pharmaceutical | 124.61B |
| Sinsin Pharmaceutical | 123.05B |
| Hwail Pharmaceutical | 107.87B |
| Sinil Pharmaceutical | 86.82B |
| Polaris AI Pharma | 63.94B |
| GL Pharm Tech | 38.21B |